Reply to Francesco Barletta, Chiara Mercinelli, Francesco Montorsi, et al. re: Improved Survival with Enzalutamide in Biochemically Recurrent Prostate Cancer. Eur Urol 2026;89:550–551

European Urology · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles